Robert Hershberg sold $402K of Adaptive Biotechnologies (ADPT)

Executed Mar 12 2025, disclosed Mar 12 2025, the same day.

Value, as filed

$402K

53,000 sh × $7.59

Executed

Mar 12 2025

the trade date, as filed

Disclosed

Mar 12 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Robert Hershberg Director profile →

Robert Hershberg (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $748K of ADPT (30,664 sh across 2 lots, as filed), executed Aug 18.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 69 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert Hershberg in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $748K
30,664 sh across 2 lots
Exec Aug 18
Filed Aug 20 · 5:55 PM ET ADPTSALE Adaptive Biotechnologies Corporation $367K
22,968 sh × $16.00
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET